Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A. Scaldaferri F, et al. Among authors: pugliese d. United European Gastroenterol J. 2020 Aug;8(7):775-781. doi: 10.1177/2050640620929133. Epub 2020 May 21. United European Gastroenterol J. 2020. PMID: 32438878 Free PMC article.
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease.
Privitera G, Onali S, Pugliese D, Renna S, Savarino E, Viola A, Ribaldone DG, Buda A, Bezzio C, Fiorino G, Fantini MC, Scaldaferri F, Guidi L, Danese S, Gasbarrini A, Orlando A, Armuzzi A. Privitera G, et al. Among authors: pugliese d. J Crohns Colitis. 2020 Jul 17:jjaa149. doi: 10.1093/ecco-jcc/jjaa149. Online ahead of print. J Crohns Colitis. 2020. PMID: 32674156
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A. Scaldaferri F, et al. Among authors: pugliese d. Inflamm Bowel Dis. 2020 Aug 20;26(9):1306-1314. doi: 10.1093/ibd/izaa181. Inflamm Bowel Dis. 2020. PMID: 32720978 Free PMC article. Review.
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients.
Pugliese D, Guidi L, Privitera G, Bertani L, Tolusso B, Papparella LG, Maltinti S, Di Mario C, Onali S, Ceccarelli L, Rapaccini GL, Scaldaferri F, Gremese E, Gasbarrini A, Costa F, Armuzzi A. Pugliese D, et al. Expert Opin Biol Ther. 2021 Jan;21(1):97-104. doi: 10.1080/14712598.2020.1839045. Epub 2020 Oct 31. Expert Opin Biol Ther. 2021. PMID: 33074723
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis.
Fiorillo C, Schena CA, Quero G, Laterza V, Pugliese D, Privitera G, Rosa F, Schepis T, Salvatore L, Di Stefano B, Larosa L, Minordi LM, Natale L, Tortora G, Armuzzi A, Alfieri S. Fiorillo C, et al. Among authors: pugliese d. Cancers (Basel). 2021 Feb 2;13(3):574. doi: 10.3390/cancers13030574. Cancers (Basel). 2021. PMID: 33540674 Free PMC article. Review.
259 results